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This study evaluated the vaccination response to Haemophilus influenzae type b (Hib) in malnourished pregnant
women (MN), cord blood (CB) and in infants at two and six months of age for comparison with a control group (C).
Twenty-eight malnourished pregnant women and 29 pregnant controls were immunized with conjugated Act-HIB®
in the third trimester of pregnancy. Blood samples were collected from all before the immunization, during labor
(post immunization), and from CB. All infants were immunized with Hib vaccine according to normal vaccine
schedule and sera were collected at two and six months of age. Antibody levels to polyribosylribitol phosphate (PRP)
were similar for both groups. Preimmunization: MN 1.94 μg/mL, C 1.68 μg/mL; post-vaccination: MN 18.53 μg/mL
and C 17.55 μg/mL; in CB from MN 14.46 μg/mL and from C 17.04 μg/mL. Infants from MN and C mothers presented
respectively at two months: 5.18 μg/mL and 8.60 μg/mL and at six months: MN 3.42 μg/mL and C 2.18 μg/mL.
Antibody levels were similar in both groups studied (p = 0.485), however the vertical transmission rate was 14%
lower in the MN pregnant group. Levels of antibodies ≥ 0.15 μg/mL were found in all newborns from the MN
pregnant group. Pregnant MN presented an immunological response to Hib vaccine similar to group C, however,
vertical transmission rate of antibodies to PRP in the MN pregnant group was 14% lower than that in C, suggesting
a less efficient passage of antibodies within this group.
Key-Words: Pregnant women, malnourished, Haemophilus influenzae type b, passive immunization, vaccine,
antibodies, immunoglobulin G.
The fetus passive immunization from the pregnant
woman’s vaccination was recognized in 1879 when Bukhardt
demonstrated the protection of children whose mothers had
been vaccinated against smallpox [1]. Some vaccines
commercially available are considered safe when administered
during pregnancy [2], and provide an increase in antibody
levels for the following pathogens: diphtheria, tetanus toxoids,
mumps, meningococcus and Hib [2-9].
Based on these results, active maternal immunization has
been proposed against other microorganisms which can cause
infection in early life such as group B streptococcus (GBS),
respiratory syncytial virus, pneumococcus, hepatitis B and
influenza [10-13].
Some studies have shown that capsular polysaccharide
vaccine PRP administered to the pregnant woman results in a
significant increase in antibody concentration to PRP in the
newborn [14] and in the four weeks old breastfed infant [9],
protecting them for up to six months or more, without affecting
their response capacity to active immunization at two, four,
six and 24 months of age [6,8,9,15].
Adequate nutrition is essential for immunocompetence,
and nutritional deficiency is a frequent cause of secondary
immunodeficiency globally [16]. There is evidence that a
relevant percentage of Brazilian women are at risk or suffer
from protein-energy malnutrition [17,18]. Furlan at al. reported
a prevalence of malnutrition during pregnancy of 27.7% [19]
and Rosado observed that 39.1% of pregnant teenagers started
pregnancy undernourished [20].
Maternal malnutrition may affect placental size decreasing
its functions by providing a smaller amount of nutrients to
the fetal organs [21], jeopardizing fetal growth and
contributing to a greater perinatal morbidity and mortality
[22,23].
The transplacental IgG transport involves a connection
to the Fc receptor on the surface of syncytiotrophoblast [24],
however, some clinical conditions such as maternal HIV
infection, malaria, prematurity and maternal
hypergammaglobulinemia may interfere with this transport, but
we did not observe reports of changes in the placental passage
of antibodies in malnourished pregnant women [25-29].
The objective of our study was to assess response to
Haemophilus influenzae type b (Hib) vaccine in malnourished
pregnant women (MN), and levels of these antibodies in cord
blood (CB) and in infants at two and six months , comparing
them to a control group  (C).
Material and methods
This study was approved by the Ethical Committee on
Research of UNIFESP and was developed at Santa Casa de
Misericórdia do Pará, a reference center in the state of Pará for
high risk pregnancies.
Twenty-eight (28) malnourished pregnant women (MN),
and 29 from a control pregnant group (C) were selected at 30-
34 weeks gestation after signed a term of consent. Women
with high risk pregnancies as chronic diseases were excluded,
also newborns with congenital anomalies.
The interviews and anthropometric assessments were
carried out by the same person under appropriate conditions.
To determine the nutritional state, Rosso normogram was used,
as recommended by the World Health Organization (WHO)
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and proposed by the Ministry of Health. The monogram
considers malnourished those pregnant women whose weight
and height relations are below 95% in early pregnancy and
123% below the ideal weight at the final stage, using the curve
of weight gain during pregnancy [30].
A single intramuscular dose of Act-HIB® vaccine (lot 3206),
Pasteur Mérieux, 0.5mL (10 mcg PRP), was administered in the
deltoid region to all the women between 30 and 34 weeks of
gestation. Adverse reactions were monitored during the first
24 hours and a week after immunization. All infants were
immunized against Hib at two, four and six months of age.
Preimmunization (immediately before vaccination) and
post-immunization (up to 24 hours after delivery) blood
samples, with a minimum interval of three weeks between pre
and post-immunization samples, were collected from 57
pregnant women (28 MN  and 29 C).  Cord blood (CB) samples
were collected from all of them. These infants were evaluated
and peripheral blood samples were collected at two (17 from
MN mothers and 20 from C) and six months of age (16 from
MN mothers and 18 C), before the first and the third Hib vaccine
doses respectively.
The blood samples were kept at -20ºC and the dosage of
specific antibodies of IgG class to PRP was done using ELISA
(BINDAZYMETM Anti-Haemophilus B - MK016) test. The
results were analyzed using the descriptive data analyses and
the following statistical tests: chi-square, repeated measures
analysis of variance, Pearson’s correlation, Student’s t-test,
all conducted through the BioEstart 3.0 software. It was
considered significant when p ≤ 0.05. Levels of antibodies ≥
0.15 μg/mL were considered protectors against infection by
Hib and ≥ 1.0 μg/mL for long term protection [31].
Results
There was a significant difference in the pregnant women’s
weight/height mean between the two groups when they were
immunized. However, the weight of newborns did not show
any difference between the two groups (Table 1).
The comparison of PRP antibody levels pre and post-
immunization between the two gestational groups (MN and
C), using repeated measured analysis of variance, did not
detect any difference between them (p = 0.485) (Table 2).
Approximately 60% of the pregnant women presented
antibody levels ≥ 1.00 μg/mL before immunization and these
levels were reached for all after immunization. Even after regular
immunization in infants, not everyone presented levels ≥ 1.00
μg/mL at six months old (Table 3) and three from the control
group had levels lower than 0.15μg/mL.
We observed a moderate to strong association between
the antibody concentration to PRP of post-immunized
pregnant women and of the CB of group C (Pearson linear
correlation = 0.583).
Applying “t” Student test for independent samples, we
observed that the ratio of placental antibody transfer to PRP
was 14% lower in the malnourished pregnant women group
(Table 4).
Discussion
Adequate nutrition is required for a good functioning of
the immunological system. Apart from the macronutrients
deficiency, subclinical deficiencies of micronutrients affect
morbid-mortality related to infection, which make them
possibly responsible for changes in humoral and cellular
immunity [32,34].  The difference in weight in the two groups,
lower in the malnourished one, despite being taller, reinforces
the classification as malnourished in this group. However,
this difference did not interfere with the baby weight at birth,
the most common interpretation of malnourishment during
pregnancy [30,35].
Studies with different types of Hib vaccine have been
used in pregnant women, as a safe and efficient way to provide
antibodies [36].  Administration is recommended after the 30th
week of gestation [9], as little maternal antibodies are
transferred to the fetus before this period.
Although the pregnant women in both groups lived in
unfavorable environments from the point of view of hygiene,
we detected very low levels of pre-immunization antibodies
to Hib. Approx  40% of pregnants   MN and  C  presented IgG
levels to PRP lower than 1 μg/mL, similar to those found in a
group of well-nourished non immunized Brazilian women [29].
The interval between mothers’ immunization and the babies
deliveries was at least three weeks, sufficient for the antibody
secretion and transplacental transfer [7]. Only three pregnant
women from group MN and one from group C did not present
an increase in the levels of  antibodies to PRP post-
immunization, however they already showed high levels at
the time of immunization. There was an average of a ten fold
increase in the mean of antibody concentration in the post-
immunization in relation to the pre-immunization, including
the pregnant group MN, who demonstrated a capacity for
response to Hib antigens. Conjugated vaccines administered
to pregnant women showed an important elevation in the
antibody levels to PRP that could be  a hundred times higher
than the pre-vaccination values [37] probably due to the
predominant induction of IgG1 antibody production,
conferring a high elevation of these antibodies to newborns
whose mothers were  immunized [29,36].
In this study, pregnant group MN  presented a
transplacental transfer of antibodies 14% lower than the
control group. Michaux et al. were the first to report that the
pattern of placental antibody transfer of IgG may decrease
when the level of this antibody reaches high values and that
the higher maternal concentration of IgG  to PRP is associated
with a less efficient transplacental transfer [38], however, we
couldn’t confirm this observation. There is no evidence in the
literature of data concerning the tansplacental transfer of
antibodies  in malnourished pregnant women.  One must
consider that the transport of antibodies across the placenta
to the fetus is an active process which requires an intact and
healthy  placenta. The inherent factors from the mother are
the ones that contribute most to the nutritive placental
insufficiency, whether through reduction of nutrients, or
Malnutrition in Pregnant Women and Hib Antibodies
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Table 1. Means of anthropometric characteristics and gestational ages of pregnant and newborns
Table 2. Serum levels of IgG(μg/mL) to polyribosylribitol phosphate (PRP) in malnourished pregnant women (MN)  and controls
(C) pre and post immunization,  cord blood (CB) and in children at 2 and 6 months of age
Table 4. Ratio of concentration of antibody placental transfer between cord blood and mother in each group
Malnutrition in Pregnant Women and Hib Antibodies
Malnourished Pregnant Value of  p of Chi-
pregnant  (MN) control (C) square test
Pregnants’ average weight at time of vaccination 56.89Kg 65.05Kg p= 0.010*
Pregnants’ average height at time of vaccination 1.56m 1.53m p= 0.038*
Average gestational ages of newborns 39.13 weeks 39.32 weeks p= 0.683
Newborns’ average weight 3.163g 3.224g p= 0.621
*p<0.05.
Group
                     Pregnant
CB 2 months 6 monthsPre- Post-
MN
Geometric mean 1.94 18.53 14.46 5.18 3.42
Minimum 0.30 8.70 5.60 0.30 0.30
Maximum 24.60 24.00 24.00 22.00 24.00
N 28 28 28 17 18
C
Geometric mean 1.68 17.55 17.04 8.60 2.18
Minimum 0.10 3.00 4.00 0.50 0.10
Maximum 21.60 24.40 23.00 22.00 24.00
N 29 29 29 20 16
N = number. ANOVA:  Pregnant MN  and C : pre < post (p=0.001*). Pregnant MN and C:  post = CB (p<0.05).
CB, 2m and 6m : MN = C (p>0.05).
Table 3.  Percentage (%) of pregnant women, newborns and infants at 2 and 6 months of age with concentration of IgG (μg/mL)
to polyribosylribitol phosphate (PRP) > 0.15μg/mL and > 1.0 μg/mL, according to nutrition status in pregnant woman
Antibody concentration  to  PRP μg/mL Malnourished (%) Control (%)
Pre-immunization ≥ 0.15 100 96.5
≥ 1.00 57.4 65.5
Post- immunization ≥ 0.15 100 100
≥ 1.00 100 100
Cord blood ≥ 0.15 100 100
≥ 1.00 100 100
2 months ≥ 0.15 100 100
≥ 1.00 94.7 95.8
6 months ≥ 0.15 100 83.3
≥ 1.00 75.0 66.6
Group Malnourished pregnant (MN) Control pregnant (C) Total
Mean 0.84* 0.98* 0.91
Standard – deviation 0.29 0.24 0.27
Minimum 0.29 0.24 0.24
Maximum 1.44 1.35 1.44
*Difference  of transference ratio between the two groups: 14%.
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through reduction of the flux of placenta [39]. The relation
between protein energy malnutrition and the baby weight at
birth has been assessed since the 50’s [1,17]. Smaller contents
of DNA, RNA and proteins have been shown in  rats born
from malnourished females by restriction of weight [40].
Infants of  two months of age  before the first immunization
against Hib, from both groups (MN and C), presented the
same antibodies levels and almost all (95%) infants had levels
of antibodies above 1 μg/mL. Similar results were observed in
the USA using conjugated vaccine - PRP-D  in breastfed
children of vaccinated mothers with PRP-T in Gâmbia [8,9].
Both of our pregnant groups studied were of a low socio-
economic level, apparently more similar to the Gambian
population than that of the USA.  Maternal malnutrition in
our pregnant women doesn’t seem to be a limiting factor in
vaccination response and in the maintenance of concentration
of these antibodies in their children at 2 months of age and at
6 months after a regular vaccine schedule.  There was no child
in pregnant group  MN with an unprotective level of Hib
antibody.
At 6 months of age, before the third dose of vaccination,
no difference was observed in the concentration of
antibodies between groups MN and C and, more than 50%
of them presented levels of protective Hib antibodies. Similar
results were found by Englund JA [9]. Mulholland K. et al,
observed that a greater number of children born from
immunized mothers presented protective levels of
antibodies to PRP, without interference with the active
immunization, when compared to children born from non-
immunized mothers during pregnancy [8]. This point must
be considered because it deals with a population that has
been exposed to high risks of infection by Hib, especially
in developing countries, when associated with the problem
of malnutrition.
From birth to 6 months of age there was a decrease in the
levels of antibodies to PRP in both groups; a consequence of
the half-life of maternal antibodies and the lack of time for the
complete immunological response  to the vaccine.
This study demonstrates an adequate immunological response
to vaccine against Hib in malnourished pregnant women.
Although the antibody concentration, was similar in the two
groups, the antibody transplacental transfer to PRP was 14%
lower in the malnourished group.  This draws attention to the
lower antibody transplacental transfer against  Hib in this
group who are considered at a higher risk to have  low birth
weight babies.
 Acknowledgments
We thank Dr. Paulo Azevedo for assistance in the research.
References
1.  Bukhardt A.E. Zur intrauterine vaccination. Deustsches Arch Clin
Med (1879) apud Linder N, Ohel G. In utero vaccination. Clin
in Perinatol 1994;1:663.
2. Amstey M.S. The potential for maternal immunization to protect
against neonatal infections. Semin Perinatol 1991;15:206-209.
3. Dengrove J., Lee E.J., Heiner D.C., et al. IgG and IgG subclass-
specific antibody responses to diphtheria and tetanus toxoids in
newborns  infants given DPT immunization. Pediatr Res
1986;20:735-9.
4. Sato H., Albrecht P., Reynolds D.W., et al. Transfer of measles,
mumps, rubella antibodies from mother to infant. Its effect on
measles, mumps, and rubella immunization. Am J Dis Child
1979;133:1240-3.
5. McCormick J., Gusmao H., Nakamura S., et al. Antibody response
to serogroup A and C meningogoccal polyssacaride vaccines in
infants born of mothers vaccinated during pregnancy. J Clin
Invest 1980;65(5):1141-4.
6. Letson W.G., Santosham M., Raymond R., et al. Comparision of
ative and combined passive/active immunization of Navarro
children against Haemophilus influenzae type b. Pediatr Infect
Dis J 1988;7:747-52.
7. Glesen P.W., Englund J.Á., Siber G.R., et al. Maternal Immunization
with capsular polysaccharide vaccine for Haemophilus
influenzae type b. J Infect Dis 1992;165:S134-6.
8. Mulholland K., Suara R.O., Siber G., et al. Maternal imunization
with Haemophilus influenzae type b polysaccharude-tetanus
protein conjugate vaccine in the Gambia. JAMA 1996;275:1181-
8.
9. Englund J.Á., Glesen W.P., Thompson C. et al. Haemophilus
influenzae type b-specific antibody in infants after maternal
immunization. Pediatr Infect Dis J 1997;16:1122-30.
10. Zaleznik D.F., Rench M.A., Hillier S., et al. Invasive disease due to
group B Streptococcus in pregnant women and neonates from
diverse population groups. Clin Infect Dis 2000;30(2):276-81.
11. Linder N., Ohel G. In utero vaccination. Clin Perinatol
1994;21:663-74.
12. Englund J.Á., Glesen W.P. Maternal Immunization for the
prevention of infection in early infancy. Semin Pediatr Infect
Dis 1991;2:225-31.
13. Centers for Disease Control. Advisory Commitee on immunization
pratices. Prevention and control of influenza. MMWR 1997;46
(RR-9):1-25 (Abstr).
14. Amstey M.S., Insel R., Munoz J., Pichichero M. Fetal-neonatal
passive immunization against Haemophilus influenzae, type b.
Am J Obstet Gynecol 1985;153:607-11.
15. Santosham M., Reid R., Ambrosino D.M., et al. Prevention of
Haemophilus influenzae type b infections in higth-risk infants
treated with bacterial polysaccharide immune globulin. N Engl J
Med 1987;317:923-9.
16. Chandra R. Immunocompetence is a sensitive and functional
barometer of nutritional status. Acta Pediatr Scand Suppl
1991;374:129-32.
17. FIBGE. Perfil Estatístico de Crianças e Mães Brasileiras. 1974-
1975. Fundação Instituto Brasileiro de Geografia e Estatística
Rio de Janeiro, RJ, 1982.
18. Engstrom E.M., Anjos L.A. Défcit estatural nas crianças brasileiras:
relação com as condições sócio-ambientais e estado nutricional
materno. Caderno Saúde Pública 1999;15(3):559-67.
19. Furlan J.P., Guazzeli C.A.F., Papa A.C.S., et al. A influência do
estado nutricional da adolescente grávida sobre o tipo de parto
e o peso do recém-nascido. Rev Bras Ginecol Obstet
2003;25(9):625-30.
20. Rosado L.E.F.P.L. Estado nutricional de gestantes adolescentes e
sua relação com o peso do recém-nascido em Viçosa MG [tese].
São Paulo: Univ. Federal de São Paulo; 1998.
21. Rosso P. Placental growth, development and function in relation
to maternal nutrition. Fed Proc 1980;39(2):250-4.
22. Greenwood B.M. Epidemiology of acute lower respiratory tract
infections, especially those due to Haemophilus influenzae type
b, in The Gambia, West Africa. J Infect Dis 1992;165:S26-8.
23. Janeway C.A. Jr., Travers P. The humoral immune response. In:
Immunobiology. The immune system in health disease. 2nd
Current Biology, London 1996;8:1-8:52.
Malnutrition in Pregnant Women and Hib Antibodies
www.bjid.com.br
BJID 2008; 12 (February) 5 1
24. Moraes-Pinto M.I., Hart C.A. Transplacental antibody transfer
and neonatal immunity. Br J Hosp Med 1997;58(7):317-9
25. Moraes-Pinto M.I., Verhoeff F., Chimsuku L., et al. Placental antibody
transfer: influence of maternal HIV infection and placental malaria.
Arch Dis Child Fetal Neonatal 1998;79:F202-F5.
26. Moraes-Pinto M.I., Farhat C.K., Carbonare S.B., et al. Maternally
acquired immunity in newborns from women infected by the
human immunodeficiency virus. Acta Paediatr
1993;82(12):1034-8.
27. Moraes-Pinto M.I., Almeida A.C.M., Kenj G., et al. Placental
transfer and maternally acquired neonatal IgG immunity in HIV
infection. J Infect Dis 1996;173(5):1077-84.
28. Brair M.-E., Brabin B.J., Milligan P., et al. Reduced transfer of
tetanus antibodies with placental malaria. Lancet
1994;343(8891):208-9.
29. Nagao AT,  Costa-Carvalho BT, Arslanian C, Sole D, Naspitz C,
Carneiro-Sampaio MM. Placent transfer of IgG against
Haemophilus influenzae type b capsular polysaccharide in
Brazilian term and preterm newborns. Journal of Tropical
Pediatrics 1999 jun;45(3):171-3.
30. Rosso P.A. New Chart to Monitor Weigth Gain during Pregnancy.
Am J Clin Nutr 1975;41:644.
31. Kayhty H., Karanko V., Peltola H., Makela P.H. The protective
level of serum antibodies to the capsular polysaccharide of
Haemophilus influenzae type b. J Infect Dis 1983;147:1100.
32. Long K.Z., Nanthakumar N. Energetic and nutritional regulation
of the adaptive immune response and trade-offs in ecological
immunology. Am J Hum Biol 2004;16(5):499-507.
Malnutrition in Pregnant Women and Hib Antibodies
33. Bhaskaram P. Immunobiology of mild micronutrient deficiencies.
Br J Nutr 2001;85 Suppl 2:S75-80.
34. B h a s k a r a m  P.  M i c r o n u t r i e n t  m a l n u t r i t i o n ,  i n f e c t i o n ,
a n d  i m m u ni ty :  an  overview.  Nutr  Rev 2002 ;60(5  Pt
2):S40-5.
35. Serrano C.V., Puffer R.R. Dados del peso ao nascer y la
mortalidade en hospitals uilizados como indicadores de los
problemas de la salud en la infancia. Bol Ofic Sanit Panamer
1975;78:93-119.
36. Englund J.A., Glezen W.P. Maternal immunization with
Haemophilus influenzae type b vaccines in different
populations. Vaccine 2003;21(24):3455-9.
37. Nahm M.H., Glensen P., Englund J. The influence of maternal
immunization on light chain response to Haemophilus
influenzae type b vaccine. Vaccine 2003;21:3393-7.
38. Michaux J.C., Heremans J.F., Hitzig W.H. Immunoglobulin levels
in cord blood serum of negroes and caucasuans. Trop Georg Med
1996;18:10-4.
39. Longo L.D. Disorders of placental transfer. In: Assau MS.
Phatophysiology of gestation. New York and London, Academic
Press 1972:1-76.
40. Barbosa A.D.M., Kolpeman B.I., Amâncio O.M.S., Patrício F.R.
Alterações de peso tecidual e histológicas placentárias,
hepáticas e pulmonares em ratas gestantes submetidas a
desnutrição e estresse crônico de nicotina e alterações de
peso tecidual e histológicas hepáticas e pulmonares e de
fosfolipídios pulmonar em seus recém-nascidos. São Paulo
1992;sn:75p.ilus,tab.
